Specific Targeting of Breast Cancer Cells with Antibodies Conjugated Gold Nanoparticles

Author(s): Zahrah Alhalili, Joe Shapter*, Daniela Figueroa, Barbara Sanderson

Journal Name: Drug Delivery Letters

Volume 8 , Issue 3 , 2018

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Background and Objective: Gold nanoparticles (AuNP) conjugated with either EpCAM or TARP antibodies and an anticancer agent, paclitaxel (PTX), for tumour targeting and therapy were synthesised using a simple chemistry.

Methods: The AuNP surface was functionalised using a two-step modification approach. The conjugates were characterised using Transmission Electron Microscopy (TEM) and infrared spectroscopy.

Results: The cytotoxicity assay of T47D cells treated with only antibodies conjugated to the gold nanoparticles did not show any cytotoxicity to the cells, which indicates these nanoconjugates are suitable for intracellular delivery of anticancer drugs.

Conclusion: When using AuNPs with antibodies and the cancer chemotherapy agent PTX attached simultaneously to the functionalised AuNPs, the reduction of cell viability was significantly higher compared to PTX-thiol-AuNPs conjugate system where no antibodies were used.

Keywords: Gold nanoparticles, paclitaxel, EpCAM, TARP, antibodies, cytotoxicity, drug delivery.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2018
Published on: 13 November, 2018
Page: [217 - 225]
Pages: 9
DOI: 10.2174/2210303108666180913115509
Price: $25

Article Metrics

PDF: 18